Reproductive Health
News on noninvasive prenatal testing, carrier screening, and preimplantation genetic screening.
Researchers confirmed prior data showing 100 percent accuracy for the test, but in a clinical-use population where they also observed growing adoption by physicians.
Federal Judge Overturns $96M Jury Verdict in Natera, CareDx Patent Case
A US District Court judge found Natera's claims of patent infringement invalid, while denying CareDx's motion for a new trial.
Researchers have begun validating the new method that can reduce lab contamination and obviate the need for lyophilization.
Sera Prognostics Prices $50M Stock Offering
The firm plans to use the proceeds to support commercial expansion in the US and EU, and for research, potential regulatory submissions, and general corporate purposes.
Aetna Revises Fetal Aneuploidy Screening Policy to Include Natera, BillionToOne Tests
The policy considers cfDNA testing medically necessary in cases such as a risk of alloimmunization and where amniocentesis is declined or contraindicated.